RIGEL PHARMACEUTICALS, INC. (RIGL) Free cash flow 2016–2023
RIGEL PHARMACEUTICALS, INC. (RIGL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.2MFY2023 · since FY2016: -$76.4M → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$6.2M | +91.7% |
| FY2022 | -$74.4M | -1711.5% |
| FY2021 | $4.6M | +108.6% |
| FY2020 | -$53.6M | -25.9% |
| FY2019 | -$42.6M | +27.8% |
| FY2018 | -$59.0M | +24.7% |
| FY2017 | -$78.4M | -2.5% |
| FY2016 | -$76.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice